Is management with lamivudine always the appropriate choice for HBV patients with onco-hematologic diseases?

By Cox M.  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 283-284

Springer Publishing Company

Access to resources Recommend Favorite

Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation

By Rosenau J.   Tillmann H.L.   Bahr M.J.   Trautwein C.   Boeker K.H.W.   Nashan B.   Klempnauer J.   Manns M.P.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3637-3638

Elsevier

Access to resources Recommend Favorite

Good results of lamivudine in hepatitis B surface antigen-positive patients with active viral replication before liver transplantation

By Gugenheim J.   Baldini E.   Ouzan D.   Sowka P.   Mouiel J.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 554-555

Elsevier

Access to resources Recommend Favorite

Intrahepatic PD-1/PD-L1 Up-regulation Closely Correlates with Inflammation and Virus Replication in Patients with Chronic HBV Infection

By Xie Zhunyi   Chen Yongwen   Zhao Songtao   Yang Zhiqing   Yao Xiaohong   Guo Sheng   Yang Chengying   Fei Lei   Zeng Xingguang   Ni Bing   Wu Yuzhang  

Immunological Investigations, Vol. 38, Iss. 7, 2009-10 ,pp. : 624-638

Informa Healthcare

Access to resources Recommend Favorite

Pretransplant crossmatching: an individualized process

By Bishara A.   Sherman L.   Brautbar C.   Claas F.   Friedlander M.   Rubinger D.   Berlatzky Y.   Papo O.   Eid A.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2708-2710

Elsevier

Access to resources Recommend Favorite